382 related articles for article (PubMed ID: 16962155)
1. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
Kim GN; Kang CY
Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
[TBL] [Abstract][Full Text] [Related]
2. Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.
Lyles DS; McKenzie MO
Virology; 1997 Mar; 229(1):77-89. PubMed ID: 9123880
[TBL] [Abstract][Full Text] [Related]
3. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.
Ahmed M; Lyles DS
Virology; 1997 Oct; 237(2):378-88. PubMed ID: 9356348
[TBL] [Abstract][Full Text] [Related]
4. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity.
Hoffmann M; Wu YJ; Gerber M; Berger-Rentsch M; Heimrich B; Schwemmle M; Zimmer G
J Gen Virol; 2010 Nov; 91(Pt 11):2782-93. PubMed ID: 20631091
[TBL] [Abstract][Full Text] [Related]
5. Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation.
Kaptur PE; McKenzie MO; Wertz GW; Lyles DS
Virology; 1995 Feb; 206(2):894-903. PubMed ID: 7856102
[TBL] [Abstract][Full Text] [Related]
6. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.
Lyles DS; McKenzie MO; Ahmed M; Woolwine SC
Virology; 1996 Nov; 225(1):172-80. PubMed ID: 8918544
[TBL] [Abstract][Full Text] [Related]
7. Determinants of serotype specificity in transcription of vesicular stomatitis virus synthetic nucleocapsids.
Smallwood S; Richards-Sumners E; Moyer SA
Virology; 1994 Feb; 199(1):11-9. PubMed ID: 8116233
[TBL] [Abstract][Full Text] [Related]
8. Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.
Kim GN; Wu K; Hong JP; Awamleh Z; Kang CY
J Virol; 2015 Jun; 89(12):6338-51. PubMed ID: 25855732
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
Ahmed M; Cramer SD; Lyles DS
Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
Martinez I; Barrera JC; Rodriguez LL; Wertz GW
Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
[TBL] [Abstract][Full Text] [Related]
11. Normal replication of vesicular stomatitis virus without C proteins.
Kretzschmar E; Peluso R; Schnell MJ; Whitt MA; Rose JK
Virology; 1996 Feb; 216(2):309-16. PubMed ID: 8607260
[TBL] [Abstract][Full Text] [Related]
12. Double-layered membrane vesicles released from mammalian cells infected with Sendai virus expressing the matrix protein of vesicular stomatitis virus.
Sakaguchi T; Uchiyama T; Fujii Y; Kiyotani K; Kato A; Nagai Y; Kawai A; Yoshida T
Virology; 1999 Oct; 263(1):230-43. PubMed ID: 10544097
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.
Ebert O; Harbaran S; Shinozaki K; Woo SL
Cancer Gene Ther; 2005 Apr; 12(4):350-8. PubMed ID: 15565179
[TBL] [Abstract][Full Text] [Related]
15. Genetically modified VSV(NJ) vector is capable of accommodating a large foreign gene insert and allows high level gene expression.
An HY; Kim GN; Wu K; Kang CY
Virus Res; 2013 Jan; 171(1):168-77. PubMed ID: 23207069
[TBL] [Abstract][Full Text] [Related]
16. Matrix protein mutations contribute to inefficient induction of apoptosis leading to persistent infection of human neural cells by vesicular stomatitis virus.
Desforges M; Despars G; Bérard S; Gosselin M; McKenzie MO; Lyles DS; Talbot PJ; Poliquin L
Virology; 2002 Mar; 295(1):63-73. PubMed ID: 12033766
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new region in the vesicular stomatitis virus L polymerase protein which is essential for mRNA cap methylation.
Grdzelishvili VZ; Smallwood S; Tower D; Hall RL; Hunt DM; Moyer SA
Virology; 2006 Jul; 350(2):394-405. PubMed ID: 16537083
[TBL] [Abstract][Full Text] [Related]
18. Common distribution of antigenic determinants and complementation activity on matrix proteins of two vesicular stomatitis virus serotypes.
Sun W; Huang L; Wagner RR
J Gen Virol; 1994 Apr; 75 ( Pt 4)():937-43. PubMed ID: 7512123
[TBL] [Abstract][Full Text] [Related]
19. Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA.
Das T; Pattnaik AK; Takacs AM; Li T; Hwang LN; Banerjee AK
Virology; 1997 Nov; 238(1):103-14. PubMed ID: 9375014
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
Senn BM; López-Macías C; Kalinke U; Lamarre A; Isibasi A; Zinkernagel RM; Hengartner H
Eur J Immunol; 2003 Apr; 33(4):950-61. PubMed ID: 12672061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
